Charles H Bombardier1, Jesse R Fann, Evette J Ludman, Steven D Vannoy, Joshua R Dyer, Jason K Barber, Nancy R Temkin. 1. Department of Rehabilitation Medicine, University of Washington, Seattle (Drs Bombardier and Dyer); Departments of Psychiatry and Behavioral Sciences, Rehabilitation Medicine and Epidemiology, University of Washington, Seattle (Dr Fann); Group Health Research Institute, Seattle, Washington (Dr Ludman); Counseling and School Psychology, University of Massachusetts, Boston (Dr Vannoy); Department of Neurological Surgery, University of Washington, Seattle (Mr Barber); and Department of Neurological Surgery and Biostatistics, University of Washington, Seattle (Dr Temkin).
Abstract
OBJECTIVE: To explore the relations of cognitive, behavioral, and physical activity variables to depression severity among people with traumatic brain injury (TBI) undergoing a depression treatment trial. SETTING: Community. PARTICIPANTS: Adults (N = 88) who sustained complicated mild to severe TBI within the past 10 years, met criteria for major depressive disorder, and completed study measures. DESIGN: Randomized controlled trial. METHODS: Participants were randomized to cognitive-behavioral therapy (n = 58) or usual care (n = 42). Outcomes were measured at baseline and 16 weeks. We combined the groups and used regressions to explore the relations among theoretical variables and depression outcomes. MAIN MEASURES: Depression severity was measured with the Hamilton Depression Rating Scale and Symptom Checklist-20. Theory-based measures were the Dysfunctional Attitudes Scale (DAS), Automatic Thoughts Questionnaire (ATQ), Environmental Rewards Observation Scale (EROS), and the International Physical Activity Questionnaire (IPAQ). RESULTS: Compared with non-TBI norms, baseline DAS and ATQ scores were high and EROS and IPAQ scores were low. All outcomes improved from baseline to 16 weeks except the DAS. The ATQ was an independent predictor of baseline depression. An increase in EROS scores was correlated with decreased depression. CONCLUSIONS: Increasing participation in meaningful roles and pleasant activities may be a promising approach to treating depression after TBI.
RCT Entities:
OBJECTIVE: To explore the relations of cognitive, behavioral, and physical activity variables to depression severity among people with traumatic brain injury (TBI) undergoing a depression treatment trial. SETTING: Community. PARTICIPANTS: Adults (N = 88) who sustained complicated mild to severe TBI within the past 10 years, met criteria for major depressive disorder, and completed study measures. DESIGN: Randomized controlled trial. METHODS:Participants were randomized to cognitive-behavioral therapy (n = 58) or usual care (n = 42). Outcomes were measured at baseline and 16 weeks. We combined the groups and used regressions to explore the relations among theoretical variables and depression outcomes. MAIN MEASURES: Depression severity was measured with the Hamilton Depression Rating Scale and Symptom Checklist-20. Theory-based measures were the Dysfunctional Attitudes Scale (DAS), Automatic Thoughts Questionnaire (ATQ), Environmental Rewards Observation Scale (EROS), and the International Physical Activity Questionnaire (IPAQ). RESULTS: Compared with non-TBI norms, baseline DAS and ATQ scores were high and EROS and IPAQ scores were low. All outcomes improved from baseline to 16 weeks except the DAS. The ATQ was an independent predictor of baseline depression. An increase in EROS scores was correlated with decreased depression. CONCLUSIONS: Increasing participation in meaningful roles and pleasant activities may be a promising approach to treating depression after TBI.
Authors: Jeanne M Hoffman; Kathleen R Bell; Janet M Powell; James Behr; Erin C Dunn; Sureyya Dikmen; Charles H Bombardier Journal: PM R Date: 2010-10 Impact factor: 2.298
Authors: Kathleen R Bell; Nancy R Temkin; Peter C Esselman; Jason N Doctor; Charles H Bombardier; Robert T Fraser; Jeanne M Hoffman; Janet M Powell; Sureyya Dikmen Journal: Arch Phys Med Rehabil Date: 2005-05 Impact factor: 3.966
Authors: P Satz; D L Forney; K Zaucha; R R Asarnow; R Light; C McCleary; H Levin; D Kelly; M Bergsneider; D Hovda; N Martin; N Namerow; D Becker Journal: Brain Inj Date: 1998-07 Impact factor: 2.311
Authors: Gro F Bertheussen; Line Oldervoll; Stein Kaasa; Jon-Arne Sandmæl; Jorunn L Helbostad Journal: Support Care Cancer Date: 2012-07-15 Impact factor: 3.603
Authors: Matthew R Powell; Allen W Brown; Danielle Klunk; Jennifer R Geske; Kamini Krishnan; Cassie Green; Thomas F Bergquist Journal: J Clin Psychol Med Settings Date: 2019-12
Authors: Patrick M Kochanek; Travis C Jackson; Ruchira M Jha; Robert S B Clark; David O Okonkwo; Hülya Bayır; Samuel M Poloyac; Amy K Wagner; Philip E Empey; Yvette P Conley; Michael J Bell; Anthony E Kline; Corina O Bondi; Dennis W Simon; Shaun W Carlson; Ava M Puccio; Christopher M Horvat; Alicia K Au; Jonathan Elmer; Amery Treble-Barna; Milos D Ikonomovic; Lori A Shutter; D Lansing Taylor; Andrew M Stern; Steven H Graham; Valerian E Kagan; Edwin K Jackson; Stephen R Wisniewski; C Edward Dixon Journal: J Neurotrauma Date: 2019-02-01 Impact factor: 5.269
Authors: Andrea Kusec; Fionnuala C Murphy; Polly V Peers; Cara Lawrence; Emma Cameron; Claire Morton; Andrew Bateman; Peter Watson; Tom Manly Journal: Pilot Feasibility Stud Date: 2020-09-22
Authors: Marta Pérez-Rodríguez; Andrea Gutiérrez-Suárez; Ruben Barakat; Javier Pérez-Tejero Journal: Medicine (Baltimore) Date: 2022-02-04 Impact factor: 1.889